Compare SIMO & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SIMO | RXRX |
|---|---|---|
| Founded | 1995 | 2013 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.3B |
| IPO Year | 2005 | 2021 |
| Metric | SIMO | RXRX |
|---|---|---|
| Price | $90.34 | $4.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $103.13 | $8.00 |
| AVG Volume (30 Days) | 274.2K | ★ 22.8M |
| Earning Date | 02-04-2026 | 11-05-2025 |
| Dividend Yield | ★ 2.25% | N/A |
| EPS Growth | ★ 8.75 | N/A |
| EPS | ★ 2.87 | N/A |
| Revenue | ★ $798,326,000.00 | $43,689,000.00 |
| Revenue This Year | $10.15 | $6.74 |
| Revenue Next Year | $17.72 | $34.31 |
| P/E Ratio | $31.04 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $37.21 | $3.79 |
| 52 Week High | $106.60 | $12.36 |
| Indicator | SIMO | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 53.00 | 43.62 |
| Support Level | $87.98 | $4.18 |
| Resistance Level | $91.19 | $4.43 |
| Average True Range (ATR) | 3.03 | 0.28 |
| MACD | 0.19 | 0.00 |
| Stochastic Oscillator | 54.21 | 14.21 |
Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.